Free weight-loss visit planner. Bring your questions to your next appointment.

Oral liquid

Compounded oral semaglutide

A dropper describes the container. Ask what the liquid contains, who prepared it and what evidence supports that formulation.

Browse guides
Illustrative Pulse+ Semaglutide oral drops bottle

Compounded medicines are not FDA-approved. The FDA does not review them for safety, effectiveness or quality before marketing. Package images are illustrations. Read the FDA’s guidance.

Distinguish drops from tablets

Oral drops are liquid. An approved semaglutide tablet and a product sold in a dropper bottle are distinct formulations. Evidence about a particular tablet or injection cannot establish how a liquid formulation behaves.

Trace the label

Ask for the full product name, the ingredient list and the name of the dispensing pharmacy. Bring a photograph of the label if an online description leaves any of this unclear.

Get an answer about approval

Ask whether the exact finished product has FDA approval and where you can verify it. If it is compounded, ask the clinician why an approved medicine would not meet your medical need.

Explore other tablets

Illustrative Pulse+ Tirzepatide tablets packaging

Tablet topic

Compounded Tirzepatide tablets

Questions to take to a clinician when an advertisement mentions tirzepatide in tablet form.

Learn more
Illustrative Pulse+ Semaglutide tablets packaging

Tablet

Compounded Semaglutide tablets

Look up the exact tablet and discuss how the product, your other medicines and your schedule fit together.

Learn more

Pulse+ visit planner

Prepare for your visit

Choose what matters to you. Take your questions to a conversation with your clinician.

What would you like to discuss?

Your selections stay in this tab until you close or reload the page.